Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cytopharm Inc Announces Appointment of CEO


Wednesday, 31 Jul 2013 05:47am EDT 

Cytopharm Inc announced that it has appointed Zeng Minghuang as Chief Executive Officer (CEO) of the Company, effective July 31, 2013. 

Company Quote

4.0
0.12 +3.09%
10 Apr 2014